Pre- and Post-Zygotic TP53 De Novo Mutations in SHH-Medulloblastoma
Li-Fraumeni syndrome (LFS) is an autosomal dominant disorder caused by mutations in the <i>TP53</i> gene, predisposing to a wide spectrum of early-onset cancers, including brain tumors. In medulloblastoma patients, the role of TP53 has been extensively investigated, though the prevalence...
Main Authors: | Jacopo Azzollini, Elisabetta Schiavello, Francesca Romana Buttarelli, Carlo Alfredo Clerici, Laura Tizzoni, Giovanna De Vecchi, Fabio Capra, Federica Pisati, Veronica Biassoni, Letterio Runza, Giorgio Carrabba, Felice Giangaspero, Maura Massimino, Valeria Pensotti, Siranoush Manoukian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2503 |
Similar Items
-
The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
by: David R. Ghasemi, et al.
Published: (2022-01-01) -
Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas
by: Otília Menyhárt, et al.
Published: (2019-03-01) -
Medulloblastoma – an overview
by: A. V. Ciurea, et al.
Published: (2010-09-01) -
Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors
by: Rachel M. Moss, et al.
Published: (2023-03-01) -
Is adult medulloblastoma merely the counterpart of pediatric medulloblastoma?
by: Gabriel Chun-Hei Wong, et al.
Published: (2020-01-01)